Recent advances in management of genital ulcer disease and anogenital warts

Dermatologic Therapy

Volumn 21, Issue 3, 2008, Pages 196-204

  Kaliaperumal, Karthikeyan ^a,b  

^a Sri Manakula Vinayagar Medical College ^*  (India)

^b Research Institute   (India)

Author keywords

Anogenital warts; Genital ulcer disease; Syphilis; Vaccines

Indexed keywords

ACICLOVIR; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FAMCICLOVIR; FLEROXACIN; IMIQUIMOD; NORFLOXACIN; PODOPHYLLOTOXIN; TETRACYCLINE; VALACICLOVIR; VIRUS VACCINE;

CONDYLOMA ACUMINATUM; DESENSITIZATION; DIAGNOSTIC TEST; FOOD AND DRUG ADMINISTRATION; GENITAL HERPES; GENITAL ULCER; GRANULOMA INGUINALE; HAEMOPHILUS DUCREYI; HUMAN; KERATINOCYTE; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SYPHILIS; ULCUS MOLLE; VACCINATION; VIRUS INFECTION; WART VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CONDYLOMATA ACUMINATA; GUIDELINES AS TOPIC; HUMANS; PAPILLOMAVIRUS VACCINES; SEXUALLY TRANSMITTED DISEASES;

EID: 45149119409     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.00191.x     Document Type: Review

References (53)

1. Centers for Disease Control Prevention. Sexually transmitted diseases treatment guidelines. Morb Mortal Wkly Rep 2006 : 55 : 14 30.
2. Chen CY, Ballard RC, Beck-Sague CM, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa. The herpetic connexion. Sex Trans Dis 2000 : 27 : 21 29.
3. Malonza IM, Tyndall MW, Ndinya-Achola JO, et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J Infect Dis 1999 : 180 : 1886 1893.
4. Htun Y, Morse SA, Dangor Y, et al. Comparison of clinically directed, disease specific, and syndromic protocols for the management of genital ulcer disease in Lesotho. Sex Transm Infect 1998 : 74 (Suppl. 1 S23 S28.
5. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda. A randomised community trial. Rakai Study Group Lancet 1999 : 353 : 525 535.
6. Makakole S, Sturm AW. Impact of herpes simplex virus (HSV) on interactions of H. ducreyi with keratinocytes: a preliminary study. Abstract WePEA4021. 13th International AIDS Conference in Durban 9-14 July 2000.
7. Plummer FA, Nsanze H, Karasira P, et al. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi. Kenya Lancet 1983 : ii : 1293 1295.
8. Trees D, Morse S. Chancroid and Haemophilus ducreyi: an update. Clin Micr Rev 1995 : 8 : 357 375.
9. Plourde PJ, D'Costa LJ, Agoki E, et al. A randomized, double blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 1992 : 165 : 949 952.
10. Schmid GP. Treatment of chancroid, 1989. Rev Infect Dis 1990 : 12 (Suppl. 6 S580 S589.
11. Guzman M, Guzman J, Bernal M. Treatment of chancroid with a single dose of spectinomycin. Sex Transm Dis 1992 : 19 : 291 294.
12. Behets FM, Liomba G, Lule G, et al. Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. J Infect Dis 1995 : 171 : 451 455.
13. Tyndall MW, Agoki E, Plummer FA, et al. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 1994 : 21 : 231 234.
14. Tyndall M, Malisa M, Plummer FA, et al. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 1993a : 167 : 469 471.
15. Tyndall MW, Plourde PJ, Agoki E, et al. Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus type 1. Am J Med 1993b : 94 : 85S 88S.
16. Rajam RV, Rangiah PN. Donovanosis (granuloma inguinale, granuloma venereum). WHO Monogr Series 1954 : 24 : 1 72.
17. Carter JS, Bowden FJ, Bastian I, Myers GM, Sriprakash KS, Kemp DJ. Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb. nov. Int J Syst Bacteriol 1999 : 49 : 1695 1700.
18. Richens J. The diagnosis and treatment of donovanosis (granuloma inguinale). Genitourin Med 1991 : 67 : 441 452.
19. Schachter J, Dawson CR. Lymphogranuloma venereum. In : Schachter J, Dawson CR, eds. Human chlamydial infections. Littleton, Mass, USA : PSG Publishing Company, 1978.
20. Mabey DCW, Wall RA, Bello CA. Aetiology of genital ulceration in the Gambia. Genitourin Med 1987 : 63 : 312 315.
21. Ndinya-Achola JO, Kihara AN, Fisher LD, et al. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi. Int J STD & AIDS 1996 : 7 : 201 205.
22. Dangor Y, Ballard R, Exposto F, et al. Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis 1990 : 17 : 184 189.
23. Behets FM, Andriamiadana J, Randrianasolo D, et al. Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. J Infect Dis 1999 : 180 : 1382 1385.
24. Ray K, Latha R, Sachdeva KG, et al. Usefulness of immunoperoxidase for serodiagnosis of genital chlamydial infections. Indian J Med Res 1993 : 97 : 67 71.
25. Viravan C, Dance DA, Ariyarit C, et al. A prospective clinical and bacteriological study of inguinal buboes in Thai men. Clin Infect Dis 1996 : 22 : 233 239.
26. Piot P, Holmes KK. Sexually transmitted diseases. In : Warren KS, Mahmoud AAF, eds. Tropical and geographical medicine, 2nd ed. New York : McGraw-Hill, 1990, Chapter 96 : 894 910.
27. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 2004 : 39 : 996 1003.
28. Perine PL, Stamm WE. Lymphogranuloma venereum. In : Holmes KK, Sparling PF, Mardh P-A, et al., eds. Sexually, transmitted diseases, 3rd ed. New York : Mc-Graw Hill, 1999, Chapter 30 : 423 432.
29. Greaves AB, Hilleman MR, Taggart SR, Bankhead AB, Feld M. Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. Bull World Health Org 1957 : 16 : 277 289.
30. Toomey KE, Barnes RC. Treatment of Chlamydia trachomatis genital infection. Rev Infect Dis 1990 : 12 (Suppl. 6 S645 S655.
31. Brugha R, Keersmaekers K, Renton A, Meheus A. Genital herpes infection: a review. Int J Epidemiol 1997 : 26 : 698 709.
32. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transmit Infect 2002 : 78 : 160 165.
33. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007 : 370 : 2127 2137.
34. Corey L, Holmes KK. Genital herpes simplex infection; current concept in diagnosis, therapy and prevention. Ann Intern Med 1983 : 98 : 973 983.
35. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus acyclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. Genitourinary Med 1997 : 73 : 110 116.
36. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002 : 34 : 958 962.
37. Chosidow O, Drouault Y, Leconte-Veyriac F, et al. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 2001 : 144 : 818 824.
38. Marks G, Nolan P, Erlich K, Ellis M. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Rev Infect Dis 1989 : 2 : 474 476.
39. Ratnam I, Chiu C, Kandala N-B, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006 : 42 : 418 427.
40. Warren T, Harris J, Brennan CA. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Clin Infect Dis 2004 : 39 (Suppl. 5 S258 S266.
41. Reyes M, Shaik NS, Graber JM, et al. Task Force on Herpes Simplex Virus Resistance. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003 : 163 : 76 80.
42. Rupp R, Rosenthal SL, Stanberry LR. Pediatrics and herpes simplex virus vaccines. Semin Pediatr Infect Dis 2005 : 16 : 31 37.
43. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002 : 347 : 1652 1661.
44. Rupp R, Rosenthal SL, Stanberry LR. VivaGel (SPL7013 Gel): a candidate dendrimer - microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine 2007 : 2 : 561 566.
45. Wohrl S, Geusau A. Clinical update; syphilis in adults. Lancet 2007 : 369 : 1912 1914.
46. Goh BT. Sexually Transmitted Infections 2005 : 81 : 448 452.
47. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005 : 353 : 1236 1244.
48. Rymark P, Forslund O, Hansson B-G, et al. Genital human papillomavirus infection is not a local but regional infection. Genitourin Med 1993 : 69 : 18 22.
49. Eron LJ. Human papillomaviruses and anogenital disease. In : Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. Philadelphia : WE Saunders, 1992 : 952 956.
50. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998 : 134 : 25 30.
51. Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004 : 23 : 569 578.
52. Pettifor A, Walsh J, Wilkins V, et al. How effective is syndromic management of STDs? A review of current studies. Sex Transm Dis 2000 : 27 : 371 385.
53. Bogaerts J, Vuylsteke B, Martinez Tello W, et al. Simple algorithms for the management of genital ulcers: evaluation in a primary health care centre in Kigali, Rwanda. Bull World Health Organ OMS 1995 : 73 : 761 767.